| 000 | 01736 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513063632.0 | ||
| 264 | 0 | _c19940609 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/oxfordjournals.annonc.a058687 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDepierre, A | |
| 245 | 0 | 0 |
_aVinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJan 1994 |
||
| 300 |
_a37-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVinblastine _xadverse effects |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aChastang, C | |
| 700 | 1 | _aQuoix, E | |
| 700 | 1 | _aLebeau, B | |
| 700 | 1 | _aBlanchon, F | |
| 700 | 1 | _aPaillot, N | |
| 700 | 1 | _aLemarie, E | |
| 700 | 1 | _aMilleron, B | |
| 700 | 1 | _aMoro, D | |
| 700 | 1 | _aClavier, J | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 5 _gno. 1 _gp. 37-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/oxfordjournals.annonc.a058687 _zAvailable from publisher's website |
| 999 |
_c8172108 _d8172108 |
||